Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Nov;54(2):595–598.

Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease.

R J Levinsky, B A Harvey, C H Rodeck, J F Soothill
PMCID: PMC1535869  PMID: 6360441

Abstract

When endotoxin was compared with phorbol myristate acetate (PMA) for stimulation of phagocytes in the nitroblue tetrazolium (NBT) test, both methods discriminated between affected patients with X-linked chronic granulomatous disease (CGD) and controls, but only the PMA NBT test distinguished female carriers of CGD. Endotoxin provided no stimulation of normal fetal blood whereas PMA was an effective stimulator. Our results indicate the superiority of the PMA NBT test for diagnosis of patients and carriers of CGD and should allow accurate antenatal diagnosis of the disease.

Full text

PDF
595

Images in this article

598Fig. 3
on p.598

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baehner R. L., Nathan D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968 May 2;278(18):971–976. doi: 10.1056/NEJM196805022781801. [DOI] [PubMed] [Google Scholar]
  2. Gifford R. H., Malawista S. E. A simple rapid micromethod for detecting chronic granulomatous disease of childhood. J Lab Clin Med. 1970 Mar;75(3):511–519. [PubMed] [Google Scholar]
  3. Gifford R. H., Malawista S. E. The nitroblue tetrazolium reaction in human granulocytes adherent to a surface. Yale J Biol Med. 1972 Apr;45(2):119–132. [PMC free article] [PubMed] [Google Scholar]
  4. Linch D. C., Beverley P. C., Levinsky R. J., Rodeck C. H. Phenotypic analysis of fetal blood leucocytes: potential for prenatal diagnosis of immunodeficiency disorders. Prenat Diagn. 1982 Jul;2(3):211–218. doi: 10.1002/pd.1970020310. [DOI] [PubMed] [Google Scholar]
  5. Newburger P. E., Cohen H. J., Rothchild S. B., Hobbins J. C., Malawista S. E., Mahoney M. J. Prenatal diagnosis of chronic granulomatous disease. N Engl J Med. 1979 Jan 25;300(4):178–181. doi: 10.1056/NEJM197901253000406. [DOI] [PubMed] [Google Scholar]
  6. Nydegger U. E., Anner R. M., Gerebtzoff A., Lambert P. H., Miescher P. A. Polymorphonuclear leukocytes stimulation by immune complexes. Assessment by nitroblue tetrazolium dye reduction. Eur J Immunol. 1973 Aug;3(8):465–470. doi: 10.1002/eji.1830030803. [DOI] [PubMed] [Google Scholar]
  7. Park H. H., Good R. A. N.B.T. test stimulated. Lancet. 1970 Sep 19;2(7673):616–616. doi: 10.1016/s0140-6736(70)90207-2. [DOI] [PubMed] [Google Scholar]
  8. Repine J. E., White J. G., Clawson C. C., Holmes B. M. Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest. 1974 Jul;54(1):83–90. doi: 10.1172/JCI107752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rodeck C. H. Fetoscopy guided by real-time ultrasound for pure fetal blood samples, fetal skin samples, and examination of the fetus in utero. Br J Obstet Gynaecol. 1980 Jun;87(6):449–456. doi: 10.1111/j.1471-0528.1980.tb04577.x. [DOI] [PubMed] [Google Scholar]
  10. Segal A. W., Cross A. R., Garcia R. C., Borregaard N., Valerius N. H., Soothill J. F., Jones O. T. Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983 Feb 3;308(5):245–251. doi: 10.1056/NEJM198302033080503. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES